Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers.

Trodelvy (sacituzumab govitecan-hziy) - Gilead

Tecentriq (atezolizumab) - Roche

QN-165 - Qualigen Therap

AE 37 - Generex

http://www.ncbi.nlm.nih.gov/pubmed/41716468

Anisha Prasad; Kazem Mashayekhi; Maryam Rahnama; Md Saidur Rahman; Shahidul M Islam

Feb 20, 2026